Many agents of differing mechanisms of action have been used in the prevention and treatment of oral mucositis induced by anticancer therapies. Currently, no intervention is completely successful at preventing or treating oral mucositis. The several solutions, drugs and methods used and studied in the...
Studies18, 19, 20 have shown the difficulty of improving the results of initial therapy in diffuse large B-cell lymphoma by the addition of novel drugs that had promising activity in studies treating recurrent disease with a single treatment group. This situation might partly reflect biological sel...
well) caused by dilation of blood vessels. This results in bringing more blood to the surface of the skin, especially in the face, making it appear red and feel hot. Certain chemo drugs cause the body to create extra heat and flushing is a reaction enabling the body to release that heat...
Agreement regarding the best TACE technique has not yet been reached, and various options concerning patient selection, delivery systems, selectivity of treatment, drugs and embolic agents injected, and repetition schedules (predefined vs‘on demand’) are still in use (Marelli et al, 2007), making...
(Malagari et al, 2008;Lammer et al, 2010), probably due to the lower doses of anticancer drugs administered. Systemic AEs, such as mucositis, alopecia, and bone marrow toxicity, were not observed in either treatment group. This safe systemic profile of cTACE could be attributed to the ...
Dose-Dense AC + weekly Taxol®can be given either before surgery (neoadjuvant) to shrink the size of the tumor, or after surgery (adjuvant) to remove any remaining breast cancer cells that may be still present in the body. Dose-Dense AC + weekly Taxol®is usually given with the goal...